Viral and host causes of fatty liver in chronic hepatitis B - Wikidata - awgldk - TriplyDB

Viral and host causes of fatty liver in chronic hepatitis B

Viral and host causes of fatty liver in chronic hepatitis B

http://www.wikidata.org/entity/Q35010958

about

Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B.Correlation between patatin-like phospholipase domain-containing protein 3 gene polymorphisms and liver cirrhosis in a chinese han population with chronic hepatitis B Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis B Comparison of first-year results of tenofovir and entecavir treatments of nucleos(t)ide-naive chronic hepatitis B patients with hepatosteatosis.Nonalcoholic fatty liver disease and HIV infection.Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis.Clinical and virological characteristics of chronic hepatitis B patients with hepatic steatosis.Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease.Hepatitis B virus infection and metabolic syndrome: fact or fiction?Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact.Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease.Sonography Predicts Liver Steatosis in Patients With Chronic Hepatitis B.Is there an influence of hepatic steatosis on fibrosis and necroinflammation in young patients with chronic viral hepatitis B?Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B.Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers.Steatosis as a co-factor in chronic liver diseases.Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome.Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B.Insulin resistance in chronic hepatitis B virus infection.Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection.Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B.Nonalcoholic fatty liver disease vs. obesity on the risk of erosive oesophagitis.Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection

P2860

Q34222246-77C4EDF2-C024-4573-B10D-D4D3F38A0074 Q34348793-5253EAA4-2399-4970-973A-E5999B955788 Q35555702-125E1B8B-CB82-41AB-B690-EFB7BDF06687 Q36449625-94CBDE06-D54A-4FDD-81E0-4F5C37DCABF4 Q36592749-FC9125E8-6E73-47CC-96A4-FD2481C12193 Q36612862-D94ABDF6-92D3-4C73-8B1C-8D8C37F837DF Q36746874-F12E7702-C843-4D59-88C2-B104E73153BF Q37454419-32D835F3-5EFB-41D0-8596-08400E8CD22E Q37552230-19A051BE-7AA0-44E4-9510-AC6D6A034601 Q38236996-7F30B55C-BB3B-459C-ACC1-522ED5FEDC46 Q38538187-F1C65FD0-A649-49C6-82E6-FD40C6B8AA27 Q38662073-55C33028-6ED3-4903-A8B2-2D1AEEF1987D Q40354353-F722EC4E-E90E-454C-82D0-0AE162111831 Q40585223-95BBD181-C573-4948-9586-AE46C51B49CD Q41221366-4EE96CF5-3BF9-47C4-A5EB-62A377A7D8D5 Q42216658-965B9978-CC22-4F0E-884A-E5A4BCB2F0FE Q42870806-35678A56-0603-4304-B060-594760774312 Q44786680-099A36F6-E622-4451-A456-82004E8EBB1C Q45227635-D20F3D99-DCB0-41E0-B75B-A57E508BFF2E Q45354091-34818F3A-7730-496F-A469-ACA98F443C55 Q45387810-95EB20FA-FE66-4AAB-AEB9-31BF7D81CAC4 Q45411012-D1E3C3ED-5623-4530-8F0C-C10BA598D81E Q46317660-271010B1-F9AB-467E-88F7-A38C82485224 Q46877112-AE2276E8-6427-41D1-A0D8-9B50BEF36E4B Q50624888-BDF11798-6461-433A-8EF9-2F28D2F40086 Q53100754-5FBA14DF-63CB-4FE7-8F6D-530EE7BF5864

P2860

Viral and host causes of fatty liver in chronic hepatitis B

http://www.wikidata.org/entity/Q35010958

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Viral and host causes of fatty liver in chronic hepatitis B

@ast

Viral and host causes of fatty liver in chronic hepatitis B

@en

type

label

Viral and host causes of fatty liver in chronic hepatitis B

@ast

Viral and host causes of fatty liver in chronic hepatitis B

@en

prefLabel

Viral and host causes of fatty liver in chronic hepatitis B

@ast

Viral and host causes of fatty liver in chronic hepatitis B

@en

P1433

Q35010958-A18C4DCE-9C9B-4CE4-90EC-275467638AE7

P1476

Q35010958-339B8F63-50DD-4AE1-A5BC-F9225D868D23

P2093

Q35010958-1B5568B8-8F7C-4047-B2C8-081E99B5B738

Q35010958-32A56A9B-6AE1-445C-9834-C82ED82F2B46

Q35010958-58E809DE-74AD-4531-94F1-4B416CD20A5F

Q35010958-8109EB79-F3B5-4AFF-A6F2-273081115185

Q35010958-841AC398-F181-447C-A3FA-DEF7C0B67D52

Q35010958-B8126FBA-4BC2-4A54-AD65-AA30E07C7795

Q35010958-EA5F6FC8-03EC-4E44-8576-5C8845649004

P2860

Q35010958-0526323C-E562-46FE-B6BF-4BD4AA9FF0A0

Q35010958-1C6629B7-B09D-4D59-89F4-D5884F7A1BC7

Q35010958-53BC3E55-C994-49A8-84D2-0817F2D0290E

Q35010958-6C7240F7-31AF-43FB-AC45-0069AC4BAAFC

Q35010958-6D9B9926-1802-4F70-B44B-CD801BEB116D

Q35010958-6EB075DD-F077-485A-80D5-A72130BFD69C

Q35010958-7DD407A3-70B0-4129-8D12-5863F32B9D53

Q35010958-A2847B8F-5F58-4F0A-930C-A489C1EA4900

Q35010958-D556DC93-54A2-4D85-9AEE-A4B9852A41B2

Q35010958-EA84D68F-644F-4B92-AA70-E5A4FCEB9E4C

P304

Q35010958-68DE26D0-AC6E-48E5-A7BF-9FC88A7F77CA

P31

Q35010958-380D8C89-5723-4555-9151-4054C1450C1E

P356

Q35010958-11913A34-6861-4F88-A85B-1424AE676C61

P407

Q35010958-9885BDF1-4E19-4457-A0B4-966FDC92F291

P433

Q35010958-7508618E-B31A-449B-B6BF-023BF7CE1064

P478

Q35010958-9EB3C6D2-B6DF-46C2-900B-E43766CA6584

P577

Q35010958-26B85B60-4499-40FD-A934-46A78DC299CB

P5875

Q35010958-FF61FC98-12C3-4273-A909-B30555253AA0

P698

Q35010958-BA443A76-5463-4CC7-AB22-C64070FFCE8E

P932

Q35010958-BD397453-A3D2-4A3B-A3B1-A06143B9DD77

P356

WJG.V11.I20.3056

P1433

World Journal of Gastroenterology

P1476

Viral and host causes of fatty liver in chronic hepatitis B

@en

P2093

Bahattin Cicek

http://www.w3.org/2001/XMLSchema#string

Emin Altlparmak

http://www.w3.org/2001/XMLSchema#string

Ertugrul Kayacetin

http://www.w3.org/2001/XMLSchema#string

Mesut Yalinkilic

http://www.w3.org/2001/XMLSchema#string

Osman Yuksel

http://www.w3.org/2001/XMLSchema#string

Seyfettin Koklu

http://www.w3.org/2001/XMLSchema#string

Tulin Sahin

http://www.w3.org/2001/XMLSchema#string

P2860

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

The natural history of nonalcoholic fatty liver: a follow-up study.

Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B.

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients.

A renal allograft recipient with viral-burden, steatoviral, and fibroviral hepatitis B who achieved remission with Lamivudine.

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

P304

3056-3059

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V11.I20.3056

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273295591

http://www.w3.org/2001/XMLSchema#string

P698

15918189

http://www.w3.org/2001/XMLSchema#string

P932

4305839

http://www.w3.org/2001/XMLSchema#string